| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -14.67M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, UNCY returned +26.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.8% |
| 1 year | +26.7% |
| 5 years | -81.7% |
| All-time high | $29.00 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in UNCY would be worth today ›No. Unicycive Therapeutics, Inc. has not paid a dividend in the past 12 months.
Unicycive Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol UNCY.
Unicycive Therapeutics, Inc. is part of the Healthcare sector.
Unicycive Therapeutics, Inc. has a market cap of 145.73M USD, based on the latest quote.
